AN2 Therapeutics
ANTX
ANTX
38 hedge funds and large institutions have $165M invested in AN2 Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.57% more ownership
Funds ownership: 48.39% → 48.95% (+0.57%)
Holders
38
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$944K | |
| 2 | +$813K | |
| 3 | +$437K | |
| 4 |
Barclays
London,
United Kingdom
|
+$390K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$299K |
Top Sellers
| 1 | -$541K | |
| 2 | -$335K | |
| 3 | -$335K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$177K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$165K |